Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05  •  04:00PM ET
19.64
Dollar change
-0.85
Percentage change
-4.15
%
IndexRUT P/E- EPS (ttm)-3.22 Insider Own17.32% Shs Outstand20.14M Perf Week15.53%
Market Cap395.64M Forward P/E18.44 EPS next Y1.06 Insider Trans-1.21% Shs Float16.66M Perf Month12.68%
Enterprise Value363.91M PEG- EPS next Q0.18 Inst Own77.71% Short Float7.65% Perf Quarter38.70%
Income-64.72M P/S5.00 EPS this Y-5.02% Inst Trans-5.05% Short Ratio2.42 Perf Half Y-28.71%
Sales79.18M P/B3.17 EPS next Y8.86% ROA-38.12% Short Interest1.27M Perf YTD-29.58%
Book/sh6.20 P/C12.23 EPS next 5Y2.22% ROE-42.13% 52W High37.67 -47.86% Perf Year-37.31%
Cash/sh1.61 P/FCF22.72 EPS past 3/5Y- - ROIC-51.69% 52W Low12.39 58.51% Perf 3Y-51.61%
Dividend Est.- EV/EBITDA24.12 Sales past 3/5Y13.67% 13.74% Gross Margin58.38% Volatility7.16% 4.73% Perf 5Y-64.91%
Dividend TTM- EV/Sales4.60 EPS Y/Y TTM-745.95% Oper. Margin8.70% ATR (14)0.93 Perf 10Y117.50%
Dividend Ex-DateJul 29, 2024 Quick Ratio7.67 Sales Y/Y TTM13.09% Profit Margin-81.74% RSI (14)65.84 Recom1.86
Dividend Gr. 3/5Y- - Current Ratio7.67 EPS Q/Q-180.48% SMA2011.35% Beta1.08 Target Price23.00
Payout- Debt/Eq0.00 Sales Q/Q-6.45% SMA5016.30% Rel Volume0.70 Prev Close20.49
Employees213 LT Debt/Eq0.00 EarningsDec 01 AMC SMA200-6.50% Avg Volume525.46K Price19.64
IPOJun 18, 1997 Option/ShortYes / Yes EPS/Sales Surpr.-11.43% 1.38% Trades Volume365,851 Change-4.15%
Date Action Analyst Rating Change Price Target Change
Sep-30-25Initiated TD Cowen Hold $16
Jul-15-25Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Nov-15-24Initiated Stephens Overweight $39
Jul-29-24Initiated KeyBanc Capital Markets Overweight $47
Jul-16-24Initiated JMP Securities Mkt Perform
Jun-28-24Initiated William Blair Outperform
May-09-23Initiated BTIG Research Buy $55
Oct-26-21Upgrade Craig Hallum Hold → Buy $65 → $53
Jan-12-21Downgrade Craig Hallum Buy → Hold
Oct-16-20Initiated Raymond James Outperform $95
Dec-04-25 12:50PM
08:56AM
Dec-02-25 03:40PM
09:06AM
12:00AM
04:32PM Loading…
Dec-01-25 04:32PM
04:05PM
Nov-28-25 07:16AM
Nov-26-25 09:49AM
Nov-24-25 10:00AM
Nov-14-25 09:55AM
Nov-06-25 08:20PM
Nov-05-25 12:37PM
12:13PM
11:57AM
11:51AM Loading…
11:51AM
10:27AM
Nov-04-25 01:46PM
Nov-03-25 12:50PM
12:43PM
12:10PM
Oct-31-25 12:53PM
Oct-29-25 10:00AM
09:55AM
08:46AM
05:45AM
Oct-22-25 07:50AM
Oct-20-25 09:38AM
Oct-07-25 05:30AM
Sep-05-25 06:34PM
07:50AM Loading…
Aug-27-25 07:50AM
Aug-11-25 03:21PM
Aug-01-25 10:39AM
10:34AM
Jul-31-25 10:56AM
10:30AM
Jul-30-25 09:54AM
Jul-29-25 08:52AM
07:50AM
Jul-28-25 08:20AM
Jul-25-25 09:18AM
Jul-24-25 10:59AM
Jul-23-25 10:22AM
10:15AM
09:52AM
Jul-19-25 02:38AM
Jul-15-25 01:56PM
09:17AM
03:02AM
Jul-14-25 04:15PM
04:13PM
04:05PM
Jul-07-25 10:00AM
Jun-18-25 04:05PM
Jun-17-25 07:58AM
Jun-14-25 08:45AM
Jun-12-25 10:18AM
07:50AM
Jun-11-25 04:30PM
Jun-05-25 05:20PM
07:50AM
Jun-03-25 10:30AM
May-21-25 10:02AM
May-19-25 08:26AM
May-15-25 07:50AM
May-02-25 09:40AM
May-01-25 09:44AM
09:38AM
Apr-29-25 08:48AM
Apr-23-25 10:24AM
07:27AM
06:01AM
Apr-21-25 07:50AM
05:42AM
Apr-16-25 08:30AM
Apr-04-25 11:24AM
08:44AM
08:02AM
03:01AM
Apr-03-25 08:44PM
05:20PM
04:17PM
04:05PM
Apr-01-25 09:04AM
Mar-20-25 07:00AM
Mar-10-25 07:00AM
Feb-04-25 07:30AM
Jan-22-25 07:50AM
Jan-13-25 07:13PM
07:50AM
Jan-08-25 07:34AM
02:00AM
Jan-07-25 05:15PM
04:16PM
04:06PM
Jan-03-25 08:15AM
Dec-17-24 04:06PM
Nov-26-24 09:55AM
Nov-22-24 07:15AM
Nov-19-24 08:30AM
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The firm operates through the Software and Services segment. The Software segment offers software products for pharmaceutical research, development, and commercialization of the firm's products. The Services segment focuses on contracted consulting studies for customers and offers services supporting marketplace insight and medical communications for clinical and commercial drug development. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LaVange LisaDirectorDec 01 '25Sale16.9186614,6449,968Dec 02 04:14 PM
LISA LAVANGEDirectorDec 01 '25Proposed Sale17.0086614,722Dec 01 04:35 PM
WOLTOSZ WALTER SDirectorOct 01 '25Sale15.3920,000307,8003,286,231Oct 03 04:13 PM
VIRGINIA EVANS WOLTOSZ & WALTEDirectorOct 01 '25Proposed Sale15.0720,000301,400Oct 01 04:29 PM
LaVange LisaDirectorSep 02 '25Sale14.1086712,2259,063Sep 04 04:18 PM
LaVange LisaDirectorAug 01 '25Sale12.9386711,2109,930Aug 04 04:21 PM
LISA LAVANGEDirectorAug 01 '25Proposed Sale13.021,73422,577Aug 01 04:29 PM
WOLTOSZ WALTER SDirectorJul 01 '25Sale18.3320,000366,6233,304,157Jul 02 04:24 PM
VIRGINIA EVANS WOLTOSZ & WALTEDirectorJul 01 '25Proposed Sale17.4560,0001,047,000Jul 01 04:34 PM
WOLTOSZ WALTER SDirectorJun 02 '25Sale27.1520,000543,0743,324,157Jun 03 04:57 PM
WOLTOSZ WALTER SDirectorMay 01 '25Sale33.5120,000670,1503,344,157May 01 05:53 PM
WOLTOSZ WALTER SDirectorApr 01 '25Sale24.0920,000481,7863,363,371Apr 02 04:20 PM
VIRGINIA EVANS WOLTOSZ & WALTEDirectorApr 01 '25Proposed Sale24.5260,0001,471,200Apr 01 04:20 PM
WOLTOSZ WALTER SDirectorMar 03 '25Sale28.6820,000573,6003,383,371Mar 04 05:08 PM
WOLTOSZ WALTER SDirectorFeb 03 '25Sale33.9120,000678,2433,402,584Feb 04 05:33 PM
WOLTOSZ WALTER SDirectorJan 02 '25Sale27.8820,000557,6623,422,584Jan 03 04:36 PM
VIRGINIA EVANS WOLTOSZ & WALTEDirectorJan 02 '25Proposed Sale27.8960,0001,673,400Jan 02 04:21 PM
WEINER DANIEL LDirectorDec 27 '24Sale28.5075021,3757,236Dec 30 04:17 PM
DANIEL LEE WEINERDirectorDec 27 '24Proposed Sale28.7875021,585Dec 27 04:17 PM